Results

Total Results: 2,111 records

Showing results for "risk".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated … What are the comparative risks, benefits, and outcomes of therapies? … What are the comparative risks, benefits, and outcomes of therapies? … However, the adjusted relative risk of surgery-related complications was lower in patients treated
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - Hb response rates: Number of studies reporting 6 15 3 Patients analyzed 2,205 3,293 659 Pooled relative … Transfusion rates: Number of studies reporting 6 34 4 Patients analyzed 2,158 5,210 950 Pooled relative … Thromboembolic events: Number of studies reporting 3 30 1 Patients analyzed 1,879 6,092 314 Pooled relative … meaningfully different. 3 Since there was only one trial, this result is a single-study (not pooled) relativerisk.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
    March 01, 2009 - Cox proportional hazards models were used to compare risks of developing the specific cause of death … with dementia. 1 “Black box” warnings were added to labels of all atypical APMs describing these risks … mainly from studies in younger populations, some have suggested that conventional APMs could pose risks … the first warnings regarding atypical agents and stroke, to avoid overestimating cerebrovascular risks … Antipsychotic drugs in dementia: what should be made of the risks?
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
    August 01, 2012 - on benefits and risks of screening, monitoring and treatment. … has been made to describe the impact of CKD stage (e.g., 1 versus 2 versus 3) on the benefits and risks … Stages 1 to 3 CKD conferred significant increases in the relative risk of all 5 parameters assessed … factors (e.g. diabetes, hypertension, etc.) on the benefits and risks of CKD screening, monitoring … factors including race on the benefits and risks of CKD screening, monitoring and treatment.
  5. effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - Harms and adverse events: – What are the risks of nonopioid pharmacologic agents for harms including … points on a 0 to 100-point scale • SMD >0.8 • RR/OR ≥2.0 MD = mean difference; OR = odds ratio; RR = relative … response with SNRI antidepressants (odds ratio [OR] 1.61 to 2.33) while we found a moderate effect (relative … ).15 Differences in magnitude could be due to the addition of 15 studies in our report, reporting relativerisks rather than odds ratios, and using direct comparisons rather than network analysis.
  6. effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
    June 02, 2011 - protocol Yes No No Conflict of interest No No Yes (optional domain of publication bias ) Types of Risks … Each study design has specific risks of bias that may differ depending on the clinical question. … classes of evidence into the review and (2) when evaluating individual studies for design-specific risks … to include observational studies, then the review team needs to evaluate each study based on the risks … presenting data on individual endpoints; 26 2. selective outcome reporting—for example, reporting relative
  7. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/impact-healthcare-algorithms-racial-ethnic-disparities-March-3.pdf
    July 01, 2023 - risk Novel risk prediction algorithm for cardiovascular disease COAG for warfarin dosing Added health … outcome variables 1 USPSTF-2020 for lung cancer risk Added measures of SDOH 1 Novel risk prediction … Novel risk prediction algorithm for postpartum depression Donor Risk Index for liver transplant suitability … deployed in health systems but regulation is not enough, and clinicians cannot bear all liability risks … How can the AI RMF help organizations manage the risks from AI bias?
  8. effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
    April 15, 2021 - In response, the EPC added a table to the discussion section on absolute risks of harms when available … presented in the context of the likelihood that this complication will occur and the difference in the relative … column whether the effect is a benefit or a harm and indicate the magnitude of effect in terms of relativerisks in the results column. … The key information about treatment risks, harms, and evidence can still be provided without relying
  9. Zikmund (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/zikmund.pdf
    May 29, 2025 - Am I at high risk or not?” … that is  higher  to this  degree.” • “My risk is  this.” • “My (group’s) risk is  this, … OR “My risk is  this   i I do X, which is higher than my risk i I do Y which is that.” • “My riskrisk for  me than that is.” • “I have bad risk.” • “My risk is  worse.” • Unclear without background … knowledge • “My risk is  worse than their  risk is.” • “My risk is  bad and worse if I do X.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-3.pdf
    June 01, 2022 - difference: CI = confidence interval; KQ = Key Question; RCT = randomized controlled trial; RR = relative … scale, 95% confidence interval [CI] −0.93 to −0.67, I2=71%), likelihood of a pain response (44 trials, relative … mitigation strategies, dose- dependent risks of opioids, and management of opioid use disorder; for … In patients with chronic pain, what are the comparative risks of opioids versus nonopioid therapies … adverse events; CI = confidence interval; MD = mean difference; RCT = randomized controlled trial; RR = relative
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
    October 27, 2017 - Treatment Description to better understand the relativerisks and benefits of these drugs based on individual patient characteristics. … A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up … "[Mesh] OR risk[tiab] OR risks[tiab] OR "Predictive Value of Tests"[Mesh] OR predict[tiab] OR predicts … "[Mesh] OR risk[tiab] OR risks[tiab] OR "Safety"[Mesh] OR safety[tiab] OR safe[tiab] OR "Incidence"[
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-other-plant-based-treatments-evidence-summary_0.pdf
    October 01, 2021 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … of sedation, and large increased risk of nausea. … Synthetic THC is probably associated with a large increased risk of dizziness. … -point scale • SMD >0.8 • RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relativerisk; SMD = standardized mean difference.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … women who did not use an antidepressant during pregnancy but whose depression status was unknown (relative … We know, however, that some baseline risks are associated with depression during pregnancy; this fact … Nonpharmacological treatments are generally thought to have fewer risks than antidepressants.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/models-care-adult-survivors-childhood-cancer-evidence-summary.pdf
    February 01, 2022 - Summary Main Points Background and Purpose Childhood cancer survivors are at increased risk … literature include oncology care versus primary care, survivor and provider knowledge (e.g., survivor risks … as described by the Stakeholders: “Survivors feel confident about sharing their history, know their risks … access relevant care and services” and “PCPs understand a survivor’s history, know the survivor’s risks … to inform delivery of survivorship-related care Survivors can share their history, know their risks
  15. S81 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - commonly used measure of discrimination, in this case equal to (sensi- tivity � specificity)/2,22 and relativerisk (RR). … risk. … 31 38.21 0.0000 Diabetes Mellitus (CCS D-50)† 0.08 4 11 97 0.54 3 3.41 0.0134 *P value is for the relativerisk.
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - All treatments have risks of complications, although frequency and severity may vary. … What are the comparative risks, benefits, and outcomes of therapies? … risk disease. … However, the relative risk of surgery-related complications adjusted for patient age, race, and comorbidity … The relative risk of surgery-related complications adjusted for patient age, race, and comorbidity,
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-blood-transfusion-protocol.pdf
    September 24, 2024 - Assessment of Methodological Risk of Bias of Individual Studies We define the risk of bias as the risk … Studies will be rated as “low risk of bias,” “medium risk of bias,” or “high risk of bias.” … Studies rated “low risk of bias” are considered to have the least risk of bias, and their results are … 100-point scale SMD >0.8 RR/OR ≥2.0 Abbreviations: MD = mean difference; OR = odds ratio; RR = relative … quality improvement; RCT = randomized controlled trial; ROSC = return of spontaneous circulation; RR = relative
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - Research and Quality (AHRQ) commissioned a comparative effectiveness review on the effectiveness and risks … assessment and initiate long-term opioid therapy only when benefits are likely to exceed risks; use … Risk Assessment and Risk Mitigation Strategies a. … Annual Surveillance Report of Drug-Related Risks and Outcomes — United States, 2017. … Annual surveillance report of drug-related risks and outcomes — United States, 2018.
  19. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
    March 01, 2022 - There may be a large increased risk of dizziness and sedation and a moderate increased risk of nausea … • Studies on the acute treatment of migraine that compare relative risks of medication overuse … studies that looked at prior or early postoperative opioid use found mostly strong associations (e.g., relative … Outcomes • Studies to assess risks and benefits including patient anxiety and disproportionate access … with antiresorptive osteoporosis drug treatment to best place these risks in the context of the effects
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - number of available tests and testing strategies, and potential tradeoffs in diagnostic accuracy, risks … We calculated relative risks (RRs) and associated 95% confidence intervals (CIs) based on the information … risk of adverse events (SOE: low) … optimized administration to be associated with lower risk of recurrence and increased risk of local … NMIBC = non–muscle-invasive bladder cancer; NMP22 = nuclear matrix protein 22; OR = odds ratio; RR = relative

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: